Sempra <SRE.N>: Truist Securities cuts target price to $100 from $107
SRE•Related News
Cabaletta Bio Q2 net loss widens as R&D costs rise
CABA•
Maitong Sunshine Q3 FY26 net loss narrows 10% to $37,684; revenue drops 100% to no revenue
MGSD•
ZenaTech signs first paying AI data center construction customer for ZenaWorx drone monitoring service
ZENA•
Healthy Choice Wellness says Host Digital signs 15-year data center lease worth $1.25 billion base term
HCWC•
Grace Therapeutics Q1 net loss widens on impairment charges
GRCE•